Shanghai Pharmaceuticals Holding Co., Ltd (HKG: 2607)

Shanghai Pharmaceuticals Holding Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	77,840	61,812	67,912	60,487	56,403	53,451
Market Cap Growth	17.84%	-8.98%	12.28%	7.24%	5.52%	3.08%
Enterprise Value	105,940	88,205	91,655	94,149	84,943	79,328
Last Close Price	12.84	10.90	11.84	12.94	11.53	12.37
PE Ratio	-	9.72	6.50	5.89	6.15	7.70
PS Ratio	0.25	0.22	0.26	0.23	0.25	0.26
PB Ratio	0.83	0.70	0.77	0.83	0.87	0.97
P/TBV Ratio	1.29	1.10	1.21	1.54	1.65	1.77
P/FCF Ratio	21.76	24.82	29.18	52.28	12.38	14.62
P/OCF Ratio	12.15	10.72	12.66	9.74	6.94	7.93
EV/Sales Ratio	0.36	0.31	0.35	0.36	0.37	0.38
EV/EBITDA Ratio	9.57	8.07	8.37	8.55	8.15	8.39
EV/EBIT Ratio	11.72	9.33	9.93	10.27	9.82	9.95
EV/FCF Ratio	29.98	35.41	39.39	81.38	18.65	21.69
Debt / Equity Ratio	0.68	0.65	0.57	0.69	0.67	0.70
Debt / EBITDA Ratio	5.46	4.89	4.29	4.24	3.90	3.84
Debt / FCF Ratio	17.63	22.96	21.67	43.25	9.58	10.59
Asset Turnover	1.25	1.27	1.28	1.38	1.34	1.41
Inventory Turnover	6.67	6.45	6.55	7.32	6.77	6.42
Quick Ratio	1.02	0.98	0.99	0.93	0.90	0.93
Current Ratio	1.34	1.33	1.35	1.27	1.22	1.31
Return on Equity (ROE)	6.41%	6.53%	10.20%	11.03%	10.77%	10.08%
Return on Assets (ROA)	2.41%	2.62%	2.82%	2.99%	3.18%	3.37%
Return on Capital (ROIC)	3.86%	4.21%	4.59%	4.88%	5.19%	5.49%
Earnings Yield	5.80%	6.72%	9.35%	10.34%	9.47%	8.54%
FCF Yield	4.60%	4.03%	3.43%	1.91%	8.07%	6.84%
Dividend Yield	4.28%	4.14%	5.83%	3.98%	4.94%	3.98%
Payout Ratio	85.84%	105.66%	55.08%	52.54%	53.79%	63.32%
Buyback Yield / Dilution	0.83%	-6.28%	-22.54%	-	-	-0.45%
Total Shareholder Return	0.83%	-2.13%	-16.72%	3.98%	4.94%	3.53%

Source: S&P Capital IQ. Standard template. Financial Sources.